<DOC>
	<DOCNO>NCT01595516</DOCNO>
	<brief_summary>The investigator hypothesize nebivolol improve endothelial t-PA release adult human elevate blood pressure great extent either metoprolol placebo . The investigator hypothesize improvement capacity vascular endothelium release t-PA nebivolol mediate , part , compound 's antioxidant property .</brief_summary>
	<brief_title>Nebivolol Endothelial Regulation Fibrinolysis ( NERF )</brief_title>
	<detailed_description />
	<mesh_term>Prehypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Subjects men woman race ethnic background age 4565 year . Subjects prehypertensive/hypertensive define rest systolic blood pressure &gt; 125 mmHg &lt; 160 mmHg and/or diastolic &gt; 80 mmHg &lt; 100 mmHg . All woman study postmenopausal receive hormone replacement therapy ( HRT ) currently precede 3year period . Candidates sedentary determine Stanford Physical Activity Questionnaire ( &lt; 35 kcal/wk ) engage program regular physical activity least 1 year prior study . Candidates smoke ( currently past 7 year ) , report lowrisk alcohol consumption define 14 standard drinks/wk 4 standard drinks/day men 7 standard drinks/wk 3 standard drinks/day woman ( standard drink define 12 ounce beer , 5 ounce wine , 1Â½ ounce 80proof distilled spirit ) . Potential candidate take cardiovascularacting ( i.e . statin , blood pressure medication aspirin ) medication eligible . Fasting plasma glucose &gt; 126 mg/dL . Potential candidate rest heart rate &lt; 50 beats/minute exclude . Use hormone replacement therapy . In hypertensive subject , seat systolic blood pressure &gt; 160 mmHg seat diastolic blood pressure &gt; 100 mmHg exclude .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>